Article
Barclays Initiates Coverage On Gossamer Bio with Overweight Rating, Announces Price Target of $9
Barclays analyst Eliana Merle initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Overweight rating and announces Price Target of $9.
Comments
- No comments yet. Be the first to comment!